[Positron emission tomography (PET) with [18F]-FDG in bronchopulmonary cancer and its impact on medical decision at the time of diagnosis, staging, or recurrence evaluation].
Grahek, D
[Positron emission tomography (PET) with [18F]-FDG in bronchopulmonary cancer and its impact on medical decision at the time of diagnosis, staging, or recurrence evaluation]. [electronic resource] - Revue de pneumologie clinique Dec 2001 - 393-403 p. digital
Publication Type: Journal Article; Review
0761-8417
Diagnosis, Differential
False Negative Reactions
False Positive Reactions
Fluorodeoxyglucose F18
Humans
Lung Neoplasms--diagnostic imaging
Neoplasm Recurrence, Local--diagnostic imaging
Neoplasm Staging
Radiopharmaceuticals
Tomography, Emission-Computed
[Positron emission tomography (PET) with [18F]-FDG in bronchopulmonary cancer and its impact on medical decision at the time of diagnosis, staging, or recurrence evaluation]. [electronic resource] - Revue de pneumologie clinique Dec 2001 - 393-403 p. digital
Publication Type: Journal Article; Review
0761-8417
Diagnosis, Differential
False Negative Reactions
False Positive Reactions
Fluorodeoxyglucose F18
Humans
Lung Neoplasms--diagnostic imaging
Neoplasm Recurrence, Local--diagnostic imaging
Neoplasm Staging
Radiopharmaceuticals
Tomography, Emission-Computed